CeciliaBlairLevandowskiMDPhD(She/Her)

PubMed

• 1 citations
  Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in KRAS-Mutant Cancers.
  Kris Wood, Daniel Nussbaum, Colin Martz, Andrew Waters, Alejandro Barrera, Justine Rutter, Christian Cerda-Smith, Amy Stewart, Chao Wu, Merve Cakir, Cecilia Levandowsk...> ;Research Square. 2023 Nov 2
• 13 citations
  The Δ40p53 isoform inhibits p53-dependent eRNA transcription and enables regulation by signal-specific transcription factors during p53 activation.
  Cecilia B. Levandowski, Taylor Jones, Margaret Gruca, Sivapriya Ramamoorthy, Robin D. Dowell, Dylan J. Taatjes> ;Plos Biology. 2021 Aug 5
• 16 citations
  Transcription factor enrichment analysis (TFEA) quantifies the activity of multiple transcription factors from a single experiment.
  Jonathan D. Rubin, Jacob T. Stanley, Rutendo F. Sigauke, Cecilia B. Levandowski, Zachary L. Maas, Jessica T. Westfall, Dylan J. Taatjes, Robin D. Dowell> ;Communications Biology. 2021 Jun 2
• 43 citations
  TFIID Enables RNA Polymerase II Promoter-Proximal Pausing.
  Charli B. Fant, Cecilia B. Levandowski, Kapil Gupta, Zachary L. Maas, Jonathan D. Rubin, Andrew Sawyer, Meagan N. Esbin, Jenna K. Rimel, Olivia Luyties, Michael T. Mar...> ;Molecular Cell. 2020 May 21
• 44 citations
  Transcriptional Responses to IFN-γ Require Mediator Kinase-Dependent Pause Release and Mechanistically Distinct CDK8 and CDK19 Functions
  Iris Steinparzer, Vitaly Sedlyarov, Jonathan D. Rubin, Kevin Eislmayr, Matthew D. Galbraith, Cecilia B. Levandowski, Terezia Vcelkova, Lucy Sneezum, Florian Wascher, F...> ;Molecular Cell. 2019 Nov 7
• 1 citations
  Wilderness dermatology: mountain exposures.
  Samantha Schneider, Cecilia B. Levandowski, Cory Manly, Robert P. Dellavalle, Cory A. Dunnick> ;Dermatology Online Journal. 2017 Nov 15
• Animal, Microbial, and Fungal Borne Skin Pathology in the Mountain Wilderness: A Review
  William E. Brandenburg, William Brower Levandowski, Tom Califf, Cory Manly, Cecilia B. Levandowski> ;Wilderness & Environmental Medicine. 2017 Jun 1
• 127 citations
  Danon Disease Clinical Features, Evaluation, and Management
  Ryan S D'Souza, Cecilia Levandowski, Dobromir Slavov, Sharon L. Graw, Larry A. Allen, Eric Adler, Luisa Mestroni, Matthew R.G. Taylor> ;Circulation. Heart Failure. 2014 Sep 1
• 147 citations
  NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome
  Cecilia B. Levandowski, Christina M. Mailloux, Tracey M. Ferrara, Katherine Gowan, Songtao Ben, Ying Jin, Kimberly K. McFann, Paulene J. Holland, Pamela R. Fain, Charl...> ;Proceedings of the National Academy of Sciences of the United States of America. 2013 Feb 19
• 258 citations
  Rapamycin Reverses Cellular Phenotypes and Enhances Mutant Protein Clearance in Hutchinson-Gilford Progeria Syndrome Cells
  Kan Cao, John J. Graziotto, Cecilia D. Blair, Joseph R. Mazzulli, Michael R. Erdos, Dimitri Krainc, Francis S. Collins> ;Science Translational Medicine. 2011 Jun 29
• 204 citations
  Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblasts
  Kan Cao, Cecilia D. Blair, Dina A. Faddah, Julia E. Kieckhaefer, Michelle Olive, Michael R. Erdos, Elizabeth G. Nabel, Francis S. Collins> ;The Journal of Clinical Investigation. 2011 Jul 1
• 272 citations
  Cardiovascular Pathology in Hutchinson-Gilford Progeria: Correlation With the Vascular Pathology of Aging
  Michelle Olive, Ingrid A. Harten, Richard N. Mitchell, Jeanette Beers, Karima Djabali, Kan Cao, Michael R. Erdos, Cecilia D. Blair, Birgit Funke, Leslie B. Smoot, Mari...> ;Arteriosclerosis, Thrombosis, and Vascular Biology. 2010 Nov 1
• 13 citations
  Sub-optimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome.
  Nur F. Önen, Edgar T. Overton, Rachel M. Presti, C. Blair, William G. Powderly, Kristin Mondy> ;HIV Medicine. 2009 Aug 1
• Join now to see all

Journal Articles

• Suppression of p53 response by targeting p53–Mediator binding with a stapled peptide.  
  Allen, B.L., Quach, K., Levandowski, C.B., Jones, T., Ebmeier, C.C., Rubin, J.D., Read, T., Dowell, R.D., Schepartz, A., Taatjes, D.J., Cell Reports